Skip to Content

Join the 'Parkinson's Disease' group to help and get support from people like you.

Parkinson's Disease News

Related terms: Parkinson's

Small Trial Provides New Hope Against Parkinson's Disease

Posted 17 days ago by Drugs.com

FRIDAY, March 1, 2019 – It may be possible to restore brain cells damaged by Parkinson's disease and reverse a patient's condition, something no current treatment can do, according to British researchers who conducted potentially groundbreaking clinical trials. They cautioned the trial was small – just 41 patients – and the research is still in its early days. But the results of the approach,...

Possible Parkinson's 'Pandemic' Looms: Report

Posted 19 Feb 2019 by Drugs.com

TUESDAY, Feb. 19, 2019 – The number of people living with Parkinson's disease worldwide could double in the next two decades, experts project. In a report warning of a possible Parkinson's "pandemic," researchers say the stage is set for cases to surge to 12 million or more by 2040. What's to blame? In large part, trends that are generally positive: Older age is a major risk factor for...

Good News, Bad News on Levodopa for Parkinson's Disease

Posted 24 Jan 2019 by Drugs.com

WEDNESDAY, Jan. 23, 2019 – The most potent drug available for Parkinson's disease, levodopa, treats symptoms of the disease but does nothing to either ease or increase its still-mysterious underlying causes, a new clinical trial has concluded. Doctors often delay prescribing levodopa, or L-dopa, to Parkinson's patients for fear that the drug might have toxic effects that produce jerky...

FDA Approves Inbrija (levodopa inhalation powder) for Intermittent Treatment of OFF Episodes in People with Parkinson’s Disease

Posted 28 Dec 2018 by Drugs.com

ARDSLEY, N.Y.--(BUSINESS WIRE) December 21, 2018 --Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration approved Inbrija™ for intermittent treatment of OFF episodes in people with Parkinson’s disease treated with carbidopa/levodopa. OFF episodes, also known as OFF periods, are defined as the return of Parkinson’s symptoms that result from low levels of dopamine betw...

Former President George H.W. Bush Dies at 94

Posted 2 Dec 2018 by Drugs.com

SATURDAY, Dec. 1, 2018 – The 41st President of the United States, George Herbert Walker Bush, died Friday night at his home in Houston at the age of 94. Bush, also the father of the 43rd President, George W. Bush, had battled numerous health issues over the past few years, including a form of Parkinson's disease, The New York Times reported. His death comes less than eight months after that of...

Parkinson's Gene Therapy Wires New Brain Circuits

Posted 28 Nov 2018 by Drugs.com

WEDNESDAY, Nov. 28, 2018 – An experimental gene therapy for Parkinson's disease seems to work by rewiring key areas of the brain, a new study finds. The researchers focused on 15 Parkinson's patients who, in an earlier trial, had received so-called GAD gene therapy. GAD is an enzyme that spurs the production of a brain chemical involved in movement control. In the previous trial, patients had...

Parkinson's Patients Can Have a Normal Life Span

Posted 1 Nov 2018 by Drugs.com

THURSDAY, Nov. 1, 2018 – If thinking skills aren't affected, a person with Parkinson's disease can live a normal life span, a new study suggests. "This is good news for many people with Parkinson's and their families," study author Dr. David Backstrom, from Umea University in Sweden, said in a news release from the American Academy of Neurology. Parkinson's is a progressive nervous system...

Could the Appendix Play a Key Role in Parkinson's Disease?

Posted 1 Nov 2018 by Drugs.com

WEDNESDAY, Oct. 31, 2018 – Long belittled as inconsequential, the appendix is hardly the rock star of body organs. But its reputation may get a boost from new research that suggests that removing it may lower the risk for Parkinson's disease. The finding follows an analysis that examined how appendix removal surgery (appendectomy) affected Parkinson's risk among 1.6 million Swedish residents....

Gene Therapy for Parkinson's Symptoms Shows Promise

Posted 25 Oct 2018 by Drugs.com

THURSDAY, Oct. 25, 2018 – A new gene therapy might help improve motor symptoms in people with Parkinson's disease who aren't responding to other therapies, an early study has found. "This is not a cure of Parkinson's disease," said James Beck, chief scientific officer of the Parkinson's Foundation. "This is a potentially good treatment for symptom control. It provides an additional way of...

ADHD Tied to Raised Risk of Early Parkinson's

Posted 12 Sep 2018 by Drugs.com

WEDNESDAY, Sept. 12, 2018 – People with attention-deficit/hyperactivity disorder (ADHD) may be more than twice as likely to develop an early onset form of Parkinson's, new research warns. What's more, among "those ADHD patients who had a record of being treated with amphetamine-like drugs – especially Ritalin [methylphenidate] – the risk dramatically increased, to between eight- to nine-fold,"...

Thinning Retina Seen as Early Warning Sign for Parkinson's

Posted 16 Aug 2018 by Drugs.com

THURSDAY, Aug. 16, 2018 – Your eyes could provide early evidence that you're developing Parkinson's disease, a small study out of South Korea suggests. People with early Parkinson's appear to experience a thinning of their retinas, which are the light-sensitive nerve cells that line the back of the eye, the researchers reported. This study is the first to specifically link retinal thinning to...

Scientists Trace Link Between Head Injuries and Parkinson's

Posted 3 Aug 2018 by Drugs.com

FRIDAY, Aug. 3, 2018 – Links between brain damage and contact sports continue to emerge, with scientists now tying repetitive head impacts to a condition that can lead to Parkinson's disease. Researchers have already tied repetitive head impacts with the brain disease chronic traumatic encephalopathy (CTE) and dementia. Now, investigators who examined 694 brains after death report ties with Lewy...

Alan Alda Reveals Parkinson's Diagnosis

Posted 31 Jul 2018 by Drugs.com

TUESDAY, July 31, 2018 – Alan Alda revealed Tuesday that he's been living with Parkinson's disease for more than three years. "The reason I want to talk about it in public is that I was diagnosed three-and-a-half years ago, and I've had a full life since," he said on the CBS television show "This Morning." The 82-year-old – who starred as Hawkeye in the hit TV series M*A*S*H – said one...

Vitamin D No Panacea for Brain Diseases

Posted 16 Jul 2018 by Drugs.com

MONDAY, July 16, 2018 – Vitamin D does little to defend your brain against multiple sclerosis, Parkinson's disease or Alzheimer's disease, a new review shows. The finding is based on an analysis of more than 70 studies. "Our work counters an emerging belief held in some quarters suggesting that higher levels of vitamin D can impact positively on brain health," said study author Krystal...

Acadia Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for Nuplazid (pimavanserin)

Posted 30 Jun 2018 by Drugs.com

SAN DIEGO--(BUSINESS WIRE)--Jun. 29, 2018-- Acadia Pharmaceuticals Inc. today announced FDA approval of a new capsule dose formulation and a new tablet strength of Nuplazid (pimavanserin) to help in the treatment of patients living with hallucinations and delusions associated with Parkinson’s disease psychosis. The FDA approval of a 34 mg Nuplazid capsule formulation will provide patients with t...

Ask a Question

Further Information

Related Drug Support Groups

Mirapex, Requip, Sinemet, ropinirole, benztropine, creatine, Cogentin, pramipexole, amantadine, levodopa